You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Genotype 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

DM1 Patients in China

Enrolling by invitation
  • Myotonic Dystrophy 1
  • Brain MRI scan
  • Shanghai, China
    Huashan Hospital
Oct 20, 2023

Impact of CES1 Genotype on Remimazolam

Not yet recruiting
  • American Society of Anesthesiologists (ASA) Class 1-2
  • +3 more
  • Remimazolam besylate
  • (no location specified)
Apr 24, 2023

Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Low Dose OXIRI (LD-OXIRI)
  • Singapore, Singapore
    National Cancer Centre, Singapore
Jun 29, 2023

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Crohn Disease, Infliximab Trial (Azathioprine, Infliximab)

    Not yet recruiting
    • Crohn Disease
    • Infliximab
    • (no location specified)
    Apr 3, 2023

    UGT1A1 Genotyping in Taiwanese Cancer Patients

    Not yet recruiting
    • The Influence of the UGT1A1 Genotype
      • (no location specified)
      Mar 20, 2023

      HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

      Recruiting
      • Drug Monitoring
      • Inflammatory Bowel Diseases
      • Tumor necrosis factor (TNF)-alpha inhibitors
      • Valladolid, Spain
        Hospital Universitario Rio Hortega
      Aug 8, 2023

      Alpha-1 Antitrypsin Deficiency Trial in Hannibal, Houston (VX-864)

      Recruiting
      • Alpha-1 Antitrypsin Deficiency
      • Hannibal, Missouri
      • +1 more
      Dec 22, 2022

      Stroke Trial in Laval (Cardiovascular training, Standard Therapy)

      Recruiting
      • Stroke
      • Cardiovascular training
      • Standard Therapy
      • Laval, Quebec, Canada
        Jewish Rehabiliation Hospital
      Nov 17, 2022

      Glucose, Circadian Rhythm, Melatonin Trial in Boston (melatonin, )

      Completed
      • Glucose
      • +3 more
      • melatonin
      • placebo
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jul 22, 2022

      Zepatier in Patients With Substance Use

      Active, not recruiting
      • Hepatitis C
      • +3 more
      • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
      • Chicago, Illinois
        University of Illinois at Chicago
      Jun 28, 2022

      Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

      Completed
      • Hepatitis C
      • Peginterferon alfa-2a
      • +2 more
      • Rotterdam, Netherlands
        Erasmus Medical Center
      Aug 26, 2021

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

      Completed
      • Hepatitis C
      • Bradford, United Kingdom
      • +3 more
      Jan 4, 2023

      Hereditary Hemorrhagic Telangiectasia, HHT, Rendu Osler Weber Disease Trial in Madrid (Registry)

      Recruiting
      • Hereditary Hemorrhagic Telangiectasia
      • +2 more
      • Registry
      • Madrid, Spain
        Hospital Universitario Ramón y Cajal
      Sep 30, 2022

      CYP1A2 Polymorphism Trial in Poznan (Intervention group with genotype information, Control group without genotype information)

      Completed
      • CYP1A2 Polymorphism
      • Intervention group with genotype information
      • Control group without genotype information
      • Poznań, Poland
        Poznan University of Life Sciences
      Feb 17, 2022

      Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

      Completed
      Has Results
      • Hepatitis C Infection
      • Hepatitis C Virus
      • (no location specified)
      Jul 28, 2021

      Hereditary Haemorrhagic Telangiectasia Trial in Bron, Clermont-Ferrand, Montpellier (Cord blood sampling, Cord sampling)

      Not yet recruiting
      • Hereditary Haemorrhagic Telangiectasia
      • Cord blood sampling
      • Cord sampling
      • Bron, France
      • +2 more
      Nov 21, 2022

      Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

      Completed
      Has Results
      • Hepatitis C Virus Infection
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Cystic Fibrosis Trial in Baltimore (VX-522)

      Recruiting
      • Cystic Fibrosis
      • VX-522
      • Baltimore, Maryland
        Baltimore - Early Phase Clinical Unit
      Jan 4, 2023

      Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

      Completed
      Has Results
      • Hepatitis C Virus Infection
      • +3 more
      • ABT-493 coformulated with ABT-530
      • (no location specified)
      Jul 9, 2021

      Hepatitis E Infection Trial in Karachi (Hecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli))., Isotonic Sodium Chloride

      Not yet recruiting
      • Hepatitis E Infection
      • Hecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli)).
      • Isotonic Sodium Chloride injection
      • Karachi, Sindh, Pakistan
        The Aga Khan University
      Mar 29, 2023

      Alpha-1 Antitrypsin Deficiency Trial in Gainesville (Alpha-1 Antitrypsin Genotype)

      Recruiting
      • Alpha-1 Antitrypsin Deficiency
      • Alpha-1 Antitrypsin Genotype
      • Gainesville, Florida
        University of Florida
      Nov 2, 2022